Cytokines and microRNAs as candidate biomarkers for systemic lupus erythematosus

Citations of this article
Mendeley users who have this article in their library.


Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, with varied course and symptoms. Its etiology is very complex and not clearly understood. There is growing evidence of the important role of cytokines in SLE pathogenesis, as well as their utility as biomarkers and targets in new therapies. Other potential new SLE biomarkers are microRNAs. Recently, over one hundred different microRNAs have been demonstrated to have a significant impact on the immune system. Various alterations in these microRNAs, associated with disease pathogenesis, have been described. They influence the signaling pathways and functions of immune response cells. Here, we aim to review the emerging new data on SLE etiology and pathogenesis.

Author supplied keywords




Stypińska, B., & Paradowska-Gorycka, A. (2015, October 13). Cytokines and microRNAs as candidate biomarkers for systemic lupus erythematosus. International Journal of Molecular Sciences. MDPI AG.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free